BrainStorm Cell Therapeutics
BCLI
#10710
Rank
โ‚ฌ9.47 M
Marketcap
0,86ย โ‚ฌ
Share price
6.52%
Change (1 day)
50.87%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -โ‚ฌ8.17 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ9.03 Million, an increase over its 2024 earnings that were of -โ‚ฌ10.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ8.17 Million-9.55%
2025 -โ‚ฌ9.03 Million-11.32%
2024 -โ‚ฌ10.19 Million-32.39%
2023 -โ‚ฌ15.07 Million-29.18%
2022 -โ‚ฌ21.27 Million-0.74%
2021 -โ‚ฌ21.43 Million-23.12%
2020 -โ‚ฌ27.87 Million36.8%
2019 -โ‚ฌ20.37 Million66.71%
2018 -โ‚ฌ12.22 Million181.66%
2017 -โ‚ฌ4.34 Million-0.6%
2016 -โ‚ฌ4.37 Million-41.31%
2015 -โ‚ฌ7.44 Million-8.22%
2014 -โ‚ฌ8.11 Million89.74%
2013 -โ‚ฌ4.27 Million42.27%
2012 -โ‚ฌ3.01 Million-12.45%
2011 -โ‚ฌ3.43 Million63.04%
2010 -โ‚ฌ2.11 Million35.52%
2009 -โ‚ฌ1.56 Million-48.99%
2008 -โ‚ฌ3.05 Million-44.39%
2007 -โ‚ฌ5.47 Million
2005 -โ‚ฌ2.84 Million-91.44%
2004 -โ‚ฌ33.1 Million94007.62%
2003 -โ‚ฌ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
โ‚ฌ1.42 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ9.39 B-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚ฌ0.7 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.73 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.10 B-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚ฌ0.23 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA